![]() | Up a level |
Toogeh, G. and Faranoush, M. and Razavi, S.M. and Jalaeikhoo, H. and Allahyari, A. and Ravanbod, M.R. and Zarrabi, F. and Fallahazad, V. and Darzi, E.R. and Fard, S.S.A. (2018) A double-blind, randomized comparison study between Zytux� vs MabThera® in treatment of CLL with FCR regimen: Non-inferiority clinical trial. International Journal of Hematology-Oncology and Stem Cell Research, 12 (2). pp. 84-91.
Toogeh, G. and Faranoush, M. and Razavi, S.M. and Jalaeikhoo, H. and Allahyari, A. and Ravanbod, M.R. and Zarrabi, F. and Fallahazad, V. and Darzi, E.R. and Fard, S.S.A. (2018) A double-blind, randomized comparison study between Zytux� vs MabThera® in treatment of CLL with FCR regimen: Non-inferiority clinical trial. International Journal of Hematology-Oncology and Stem Cell Research, 12 (2). pp. 84-91.
Mirzania, M. and Ghavamzadeh, A. and Kermani, I.A. and Ashrafi, F. and Allahyari, A. and Rostami, N. and Razavi, S.M. and Ramzi, M. and Nemanipour, G. (2015) Medical oncology, history and its future in Iran. Archives of Iranian Medicine, 18 (11). pp. 799-805.